Our observations, particularly regarding cytokines like IL-1ra, IL-1α, VEGF, and IL-6, enhance our understanding of MS pathophysiology and pave the way for advancements in MS research and clinical management. This evidence concerns the gene VEGFA and myeloid sarcoma.